Latest Merger And Acquisition News

Warriedar Resources shareholders have overwhelmingly approved a scheme of arrangement for acquisition by Capricorn Metals, clearing a key hurdle ahead of final court approval and delisting.

Greenvale Energy has raised approximately $1.05 million through a share placement to fund ongoing uranium exploration at its Oasis project, with a Security Purchase Plan also offered to shareholders.

Aeris Resources has bolstered its financial position by completing an $80 million placement and repaying $40 million of debt early, setting the stage for growth in FY26.

Bentley Capital Limited has addressed a sharp 70% rise in its share price and a spike in trading volume, attributing the movement to ongoing legal proceedings rather than undisclosed information.

Medibank is set to acquire Better Medical, a network of 61 GP clinics across four states, for approximately $159 million, enhancing its primary care footprint and preventive health initiatives.

Group One Capital Limited has appointed Ross Patane as Managing Director and CEO, marking a strategic leadership transition with seasoned expertise at the helm.

Kingsrose Mining advances exploration in Norway’s Finnmark region with new geophysical anomalies, while navigating permitting challenges in Finland and focusing on strategic M&A under new leadership.

Elevate Uranium has raised $25 million through a well-supported placement, boosting its cash reserves to nearly $44 million. The funds will accelerate its proprietary U-pgrade™ pilot plant and expand uranium resource drilling in Namibia and Australia.

Integral Diagnostics reports a robust FY25 with revenue climbing 33.7% to $628 million, driven by successful Capitol Health merger integration and strong growth in teleradiology. CEO Dr Ian Kadish announces retirement after eight transformative years.

EZZ Life Science Holdings reported a 25% drop in Q1 receipts, driven by seasonal softness and campaign timing, while accelerating its US market entry and launching three new health supplements.

EQT Holdings Limited reported a robust 60% increase in net profit after tax for FY25, completing a strategic transformation while navigating significant regulatory challenges. The company outlined a growth-focused strategy for FY26, emphasizing digital innovation and margin improvement.

Little Green Pharma reported a robust September quarter with revenue exceeding $10 million, driven by growth across all product lines and strong European market performance. The company is poised to benefit from upcoming regulatory reforms and operational efficiencies.